Geron CorpNASDAQ:GERN
- LAST PRICE4.6600
- TODAY'S CHANGE (%)0.3700 (8.6247%)
- Bid / Lots4.6400/ 1
- Ask / Lots4.6800/ 216
- Open / Previous Close4.3500 / 4.2900
- Day Range
- 52 Week Range
- Volume12,881,203
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | GERN |
|---|---|---|
| 09:32 ET | 154336 | 4.485 |
| 09:34 ET | 310392 | 4.52 |
| 09:36 ET | 198734 | 4.5895 |
| 09:38 ET | 319142 | 4.5603 |
| 09:39 ET | 133047 | 4.49 |
| 09:41 ET | 211946 | 4.52 |
| 09:43 ET | 37942 | 4.555 |
| 09:45 ET | 150334 | 4.57 |
| 09:48 ET | 167001 | 4.61 |
| 09:50 ET | 158843 | 4.66 |
| 09:52 ET | 109079 | 4.69 |
| 09:54 ET | 130646 | 4.715 |
| 09:56 ET | 62557 | 4.71 |
| 09:57 ET | 73573 | 4.74 |
| 09:59 ET | 89452 | 4.705 |
| 10:01 ET | 305361 | 4.62 |
| 10:03 ET | 287105 | 4.62 |
| 10:06 ET | 43949 | 4.6165 |
| 10:08 ET | 69163 | 4.61 |
| 10:10 ET | 93943 | 4.59 |
| 10:12 ET | 73772 | 4.605 |
| 10:14 ET | 262281 | 4.595 |
| 10:15 ET | 125643 | 4.6 |
| 10:17 ET | 58847 | 4.61 |
| 10:19 ET | 77828 | 4.5806 |
| 10:21 ET | 19283 | 4.57 |
| 10:24 ET | 39191 | 4.55 |
| 10:26 ET | 41517 | 4.55 |
| 10:28 ET | 423275 | 4.575 |
| 10:30 ET | 49310 | 4.565 |
| 10:32 ET | 68011 | 4.555 |
| 10:33 ET | 98974 | 4.575 |
| 10:35 ET | 157595 | 4.5794 |
| 10:37 ET | 217937 | 4.5534 |
| 10:39 ET | 58329 | 4.59 |
| 10:42 ET | 66780 | 4.58 |
| 10:44 ET | 63447 | 4.555 |
| 10:46 ET | 10625 | 4.55 |
| 10:48 ET | 12765 | 4.555 |
| 10:50 ET | 88165 | 4.555 |
| 10:51 ET | 3800 | 4.55 |
| 10:53 ET | 30173 | 4.555 |
| 10:55 ET | 30153 | 4.55 |
| 10:57 ET | 8150 | 4.56 |
| 11:00 ET | 52878 | 4.555 |
| 11:02 ET | 2375 | 4.55 |
| 11:04 ET | 121866 | 4.57 |
| 11:06 ET | 10221 | 4.57 |
| 11:08 ET | 407742 | 4.56 |
| 11:09 ET | 5900 | 4.555 |
| 11:11 ET | 19367 | 4.555 |
| 11:13 ET | 381510 | 4.535 |
| 11:15 ET | 54253 | 4.525 |
| 11:18 ET | 21263 | 4.54 |
| 11:20 ET | 81441 | 4.565 |
| 11:22 ET | 39254 | 4.55 |
| 11:24 ET | 16433 | 4.565 |
| 11:26 ET | 8738 | 4.56 |
| 11:27 ET | 20068 | 4.565 |
| 11:29 ET | 46218 | 4.565 |
| 11:31 ET | 3956 | 4.565 |
| 11:33 ET | 15167 | 4.56 |
| 11:36 ET | 82202 | 4.56 |
| 11:38 ET | 3100 | 4.58 |
| 11:40 ET | 200 | 4.575 |
| 11:42 ET | 115103 | 4.56 |
| 11:44 ET | 21052 | 4.5599 |
| 11:45 ET | 26566 | 4.56 |
| 11:47 ET | 28951 | 4.565 |
| 11:49 ET | 6553 | 4.56 |
| 11:51 ET | 1000 | 4.56 |
| 11:54 ET | 4500 | 4.565 |
| 11:56 ET | 33871 | 4.565 |
| 11:58 ET | 3175 | 4.57 |
| 12:00 ET | 2634 | 4.5647 |
| 12:02 ET | 39958 | 4.56 |
| 12:03 ET | 145630 | 4.585 |
| 12:05 ET | 8414 | 4.57 |
| 12:07 ET | 8648 | 4.58 |
| 12:09 ET | 13881 | 4.5855 |
| 12:12 ET | 5301 | 4.584 |
| 12:14 ET | 48250 | 4.595 |
| 12:16 ET | 172352 | 4.605 |
| 12:18 ET | 231138 | 4.605 |
| 12:20 ET | 14761 | 4.6011 |
| 12:21 ET | 5923 | 4.605 |
| 12:23 ET | 4244 | 4.605 |
| 12:25 ET | 8668 | 4.605 |
| 12:27 ET | 1533 | 4.605 |
| 12:30 ET | 7160 | 4.61 |
| 12:32 ET | 44605 | 4.6 |
| 12:34 ET | 37475 | 4.605 |
| 12:36 ET | 61116 | 4.605 |
| 12:38 ET | 4202 | 4.61 |
| 12:39 ET | 22605 | 4.615 |
| 12:41 ET | 22006 | 4.62 |
| 12:43 ET | 39378 | 4.635 |
| 12:45 ET | 17383 | 4.6399 |
| 12:48 ET | 65612 | 4.635 |
| 12:50 ET | 21343 | 4.615 |
| 12:52 ET | 2212 | 4.615 |
| 12:54 ET | 34259 | 4.605 |
| 12:56 ET | 14720 | 4.6 |
| 12:57 ET | 4600 | 4.6001 |
| 12:59 ET | 27411 | 4.595 |
| 01:01 ET | 29687 | 4.6101 |
| 01:03 ET | 12877 | 4.615 |
| 01:06 ET | 22866 | 4.63 |
| 01:08 ET | 14093 | 4.62 |
| 01:10 ET | 3173 | 4.615 |
| 01:12 ET | 3300 | 4.62 |
| 01:14 ET | 10285 | 4.615 |
| 01:15 ET | 178773 | 4.595 |
| 01:17 ET | 77307 | 4.6 |
| 01:19 ET | 17481 | 4.585 |
| 01:21 ET | 236008 | 4.595 |
| 01:24 ET | 4477 | 4.6 |
| 01:26 ET | 17433 | 4.605 |
| 01:28 ET | 1805 | 4.605 |
| 01:30 ET | 42416 | 4.6 |
| 01:32 ET | 10388 | 4.6 |
| 01:33 ET | 9341 | 4.595 |
| 01:35 ET | 15111 | 4.575 |
| 01:37 ET | 16622 | 4.58 |
| 01:39 ET | 16758 | 4.575 |
| 01:42 ET | 12844 | 4.595 |
| 01:44 ET | 19524 | 4.605 |
| 01:46 ET | 17291 | 4.61 |
| 01:48 ET | 44575 | 4.605 |
| 01:50 ET | 165143 | 4.605 |
| 01:51 ET | 11002 | 4.61 |
| 01:53 ET | 13799 | 4.615 |
| 01:55 ET | 19824 | 4.61 |
| 01:57 ET | 16200 | 4.605 |
| 02:00 ET | 15097 | 4.6099 |
| 02:02 ET | 4640 | 4.605 |
| 02:04 ET | 26079 | 4.62 |
| 02:06 ET | 14410 | 4.61 |
| 02:08 ET | 4712 | 4.605 |
| 02:09 ET | 41423 | 4.615 |
| 02:11 ET | 4119 | 4.615 |
| 02:13 ET | 5018 | 4.615 |
| 02:15 ET | 6600 | 4.615 |
| 02:18 ET | 35911 | 4.624 |
| 02:20 ET | 33604 | 4.61 |
| 02:22 ET | 4800 | 4.61 |
| 02:24 ET | 10395 | 4.61 |
| 02:26 ET | 3658 | 4.6181 |
| 02:27 ET | 12573 | 4.61 |
| 02:29 ET | 37955 | 4.62 |
| 02:31 ET | 23505 | 4.625 |
| 02:33 ET | 27870 | 4.625 |
| 02:36 ET | 16856 | 4.6203 |
| 02:38 ET | 11080 | 4.625 |
| 02:40 ET | 2520 | 4.625 |
| 02:42 ET | 5700 | 4.62 |
| 02:44 ET | 111325 | 4.62 |
| 02:45 ET | 65607 | 4.635 |
| 02:47 ET | 30525 | 4.625 |
| 02:49 ET | 6250 | 4.625 |
| 02:51 ET | 28459 | 4.64 |
| 02:54 ET | 24024 | 4.635 |
| 02:56 ET | 5512 | 4.635 |
| 02:58 ET | 37540 | 4.64 |
| 03:00 ET | 41464 | 4.64 |
| 03:02 ET | 12321 | 4.635 |
| 03:03 ET | 4000 | 4.64 |
| 03:05 ET | 14815 | 4.635 |
| 03:07 ET | 51334 | 4.645 |
| 03:09 ET | 20321 | 4.645 |
| 03:12 ET | 16818 | 4.645 |
| 03:14 ET | 83331 | 4.655 |
| 03:16 ET | 7596 | 4.655 |
| 03:18 ET | 9093 | 4.66 |
| 03:20 ET | 12912 | 4.655 |
| 03:21 ET | 43318 | 4.665 |
| 03:23 ET | 17086 | 4.665 |
| 03:25 ET | 79926 | 4.675 |
| 03:27 ET | 67364 | 4.685 |
| 03:30 ET | 18201 | 4.7 |
| 03:32 ET | 2981 | 4.695 |
| 03:34 ET | 66497 | 4.675 |
| 03:36 ET | 44411 | 4.66 |
| 03:38 ET | 19366 | 4.665 |
| 03:39 ET | 29698 | 4.665 |
| 03:41 ET | 52056 | 4.665 |
| 03:43 ET | 20129 | 4.66 |
| 03:45 ET | 174455 | 4.665 |
| 03:48 ET | 18403 | 4.655 |
| 03:50 ET | 38768 | 4.655 |
| 03:52 ET | 101071 | 4.665 |
| 03:54 ET | 78856 | 4.65 |
| 03:56 ET | 201907 | 4.65 |
| 03:57 ET | 92311 | 4.655 |
| 03:59 ET | 804211 | 4.66 |
Today
DJ Geron Price Target Maintained With a $6.00/Share by Needham, from 3 hours ago by Dow Jones
3 hours ago by Dow JonesGeron Announces Updated NCCN Guidelines(R) Recommending RYTELO(TM) (imetelstat) for the Treatment of Symptomatic Anemia in Patients with Lower-Risk MDS, from 12 hours ago by Dow Jones
12 hours ago by Dow Jones
Jul 23, 2024
DJ Geron Shares Drop as Chief Commercial Officer Set to Exit >GERN, from 5:51PM ET on Tuesday Jul 23, 2024 by Dow Jones
5:51PM ET on Tuesday Jul 23, 2024 by Dow JonesGeron Corporation Announces Chief Commercial Officer to Depart at End of August 2024, from 4:15PM ET on Tuesday Jul 23, 2024 by Dow Jones
4:15PM ET on Tuesday Jul 23, 2024 by Dow Jones*DJ Geron Corp Announces Chief Comml Officer Anil Kapur to Depart at End of Aug 2024, from 4:15PM ET on Tuesday Jul 23, 2024 by Dow Jones
4:15PM ET on Tuesday Jul 23, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Geron Corp | 2.5B | -13.5x | --- |
Iovance Biotherapeutics Inc | 2.6B | -5.1x | --- |
Rocket Pharmaceuticals Inc | 2.3B | -8.8x | --- |
SpringWorks Therapeutics Inc | 2.7B | -7.4x | --- |
Intellia Therapeutics Inc | 2.5B | -4.9x | --- |
Morphic Holding Inc | 2.8B | -16.2x | --- |
Company Information
Geron Corporation is a late-stage clinical biopharmaceutical company developing investigational first-in-class telomerase inhibitor, imetelstat, to treat hematologic malignancies. The Company is engaged in the development of therapeutic products for oncology. Its lead indication for imetelstat is in Low or Intermediate-1 risk myelodysplastic syndromes. It is developing imetelstat for the treatment of several myeloid hematologic malignancies, including a Phase 3 clinical trial, named IMpactMF, in relapsed/refractory myelofibrosis (MF) with overall survival as the primary endpoint, that is enrolling patients. It is also conducting a Phase 1 combination therapy clinical trial, named IMproveMF, in first-line Intermediate-1, Intermediate-2 or High-Risk myelofibrosis, or frontline MF, that is enrolling patients and imetelstat is being studied in an investigator-led Phase 2 clinical trial, named IMpress, in Intermediate-2 or High-Risk myelodysplastic syndromes and acute myeloid leukemia.
Contact Information
- Headquarters
- 919 East Hillsdale Boulevard, Suite 250FOSTER CITY, CA, United States 94404
- Phone
- 650-473-7700
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer
- John Scarlett
- Chief Financial Officer, Executive Vice President - Finance, Treasurer
- Michelle Robertson
- Executive Vice President, Chief Operating Officer
- Andrew Grethlein
- Chief People Officer, Senior Vice President
- Shannon Odam
- Executive Vice President, Chief Legal Officer, Secretary
- Scott Samuels
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.5B |
|---|---|
Revenue (TTM) | $520.0K |
Shares Outstanding | 593.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.48 |
EPS | $-0.35 |
Book Value | $0.46 |
P/E Ratio | -13.5x |
Price/Sales (TTM) | 4,893.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -40,381.92% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
